Danan C, Naughton K, Hayer K, Vellappan S, McMillan E, Zhou Y
JCI Insight. 2023; 8(23).
PMID: 37883185
PMC: 10795831.
DOI: 10.1172/jci.insight.171657.
Fanini F, Bandini E, Plousiou M, Carloni S, Wise P, Neviani P
Int J Mol Sci. 2021; 22(24).
PMID: 34948154
PMC: 8705178.
DOI: 10.3390/ijms222413357.
Krzyzanowski D, Kruszewski M, Grzelak A
Materials (Basel). 2021; 14(12).
PMID: 34207361
PMC: 8234686.
DOI: 10.3390/ma14123383.
Kondo H, Miyoshi K, Sakiyama S, Tangoku A, Noma T
Stem Cells Int. 2015; 2015:165867.
PMID: 26167183
PMC: 4488158.
DOI: 10.1155/2015/165867.
Prasanphanich A, Arencibia C, Kemp M
Free Radic Biol Med. 2014; 76:1-13.
PMID: 25088330
PMC: 4254148.
DOI: 10.1016/j.freeradbiomed.2014.07.032.
E-cadherin-downregulation and RECK-upregulation are coupled in the non-malignant epithelial cell line MCF10A but not in multiple carcinoma-derived cell lines.
Yuki K, Yoshida Y, Inagaki R, Hiai H, Noda M
Sci Rep. 2014; 4:4568.
PMID: 24691523
PMC: 3972504.
DOI: 10.1038/srep04568.
The proto-oncogene KRAS is targeted by miR-200c.
Kopp F, Wagner E, Roidl A
Oncotarget. 2013; 5(1):185-95.
PMID: 24368337
PMC: 3960200.
DOI: 10.18632/oncotarget.1427.
Oncolytic bluetongue viruses: promise, progress, and perspectives.
Li J
Front Microbiol. 2011; 2:46.
PMID: 21747785
PMC: 3128942.
DOI: 10.3389/fmicb.2011.00046.
Hypoxia in models of lung cancer: implications for targeted therapeutics.
Graves E, Vilalta M, Cecic I, Erler J, Tran P, Felsher D
Clin Cancer Res. 2010; 16(19):4843-52.
PMID: 20858837
PMC: 2948600.
DOI: 10.1158/1078-0432.CCR-10-1206.
Increased cell migration and plasticity in Nrf2-deficient cancer cell lines.
Rachakonda G, Sekhar K, Jowhar D, SAMSON P, Wikswo J, Beauchamp R
Oncogene. 2010; 29(25):3703-14.
PMID: 20440267
PMC: 2892014.
DOI: 10.1038/onc.2010.118.
The CRAL/TRIO and GOLD domain protein TAP-1 regulates RAF-1 activation.
Johnson K, Kornfeld K
Dev Biol. 2010; 341(2):464-71.
PMID: 20230813
PMC: 2877037.
DOI: 10.1016/j.ydbio.2010.03.003.
Human cancers converge at the HIF-2alpha oncogenic axis.
Franovic A, Holterman C, Payette J, Lee S
Proc Natl Acad Sci U S A. 2009; 106(50):21306-11.
PMID: 19955413
PMC: 2795516.
DOI: 10.1073/pnas.0906432106.
Absence of GAPDH regulation in tumor-cells of different origin under hypoxic conditions in - vitro.
Said H, Polat B, Hagemann C, Anacker J, Flentje M, Vordermark D
BMC Res Notes. 2009; 2:8.
PMID: 19144146
PMC: 2646737.
DOI: 10.1186/1756-0500-2-8.
K-ras mutations in sinonasal cancers in relation to wood dust exposure.
Bornholdt J, Hansen J, Steiniche T, Dictor M, Antonsen A, Wolff H
BMC Cancer. 2008; 8:53.
PMID: 18289366
PMC: 2278146.
DOI: 10.1186/1471-2407-8-53.
MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy.
Weidhaas J, Babar I, Nallur S, Trang P, Roush S, Boehm M
Cancer Res. 2007; 67(23):11111-6.
PMID: 18056433
PMC: 6070379.
DOI: 10.1158/0008-5472.CAN-07-2858.
Expression profiling of genes regulated by TGF-beta: differential regulation in normal and tumour cells.
Ranganathan P, Agrawal A, Bhushan R, Chavalmane A, Kalathur R, Takahashi T
BMC Genomics. 2007; 8:98.
PMID: 17425807
PMC: 1858692.
DOI: 10.1186/1471-2164-8-98.
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer.
Zhou B, Peyton M, He B, Liu C, Girard L, Caudler E
Cancer Cell. 2006; 10(1):39-50.
PMID: 16843264
PMC: 4451119.
DOI: 10.1016/j.ccr.2006.05.024.
Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides.
Schirmer A, Kennedy J, Murli S, Reid R, Santi D
Proc Natl Acad Sci U S A. 2006; 103(11):4234-9.
PMID: 16537514
PMC: 1449676.
DOI: 10.1073/pnas.0600445103.
Specific T-cell immunity against Ki-ras peptides in patients with pancreatic and colorectal cancers.
Shono Y, Tanimura H, Iwahashi M, Tsunoda T, Tani M, Tanaka H
Br J Cancer. 2003; 88(4):530-6.
PMID: 12592366
PMC: 2377177.
DOI: 10.1038/sj.bjc.6600697.
K-RAS mutation in transitional cell carcinoma of urinary bladder.
Ayan S, Gokce G, Kilicarslan H, Ozdemir O, Yildiz E, Gultekin E
Int Urol Nephrol. 2002; 33(2):363-7.
PMID: 12092657
DOI: 10.1023/a:1015213713048.